ライフサイエンスコーパス: Crohn's colitis

1 are widely used surgical options in isolated Crohn's colitis.

2 reduced STAT3 activation in both murine and Crohn's colitis.

3 ice and in biopsy samples from patients with Crohn's colitis.

4 be strongly considered in chronic extensive Crohn's colitis.

5 hyperplastic polyps, ulcerative colitis, and Crohn's colitis.

6 s a rare case of EC in a patient with severe Crohn's colitis.

7 (GBPs) with tuberculosis susceptibility and Crohn's colitis.

8 n the appropriate management of dysplasia in Crohn's colitis.

9 This study evaluates surgical procedures for Crohn's colitis.

10 eillance for neoplasia in Australia (23 with Crohn's colitis, 29 with ulcerative colitis; median age,

11 Guts UK, Crohn's and Colitis UK, Cure Crohn's Colitis, AbbVie, Merck Sharp and Dohme, Napp Pha

12 l of our patients with chronic ulcerative or Crohn's colitis and dysplastic polyps and no coexistent

13 metronidazole and/or ciprofloxacin can treat Crohn's colitis and ileocolitis (but not isolated ileal

14 risons of MLH1 exon 15/D3S1611 haplotypes of Crohn's colitis and patients with ulcerative colitis wer

15 ErbB4 levels increased in Crohn's colitis and the colon epithelium of mice with DS

16 illance colonoscopy in patients with chronic Crohn's colitis and therefore little agreement as to whe

17 ion was absent from normal colon, whereas in Crohn's colitis and ulcerative colitis, COX-2 was observ

18 Immunohistochemistry of normal, Crohn's colitis, and ulcerative colitis tissue showed eq

19 2009, 50 patients underwent a colectomy for Crohn's colitis-associated dysplasia.

20 oup, Gandel Philanthropy, Angior Foundation, Crohn's Colitis Australia, and the National Health and M

21 rtiary IBD centres, social media and through Crohn's Colitis Australia.

22 rentiate between ulcerative colitis (UC) and Crohn's colitis (CC) in one-third of patients with predo

23 Patients with ulcerative colitis and Crohn's colitis face an increased lifetime risk of devel

24 a-abdominal surgery across 17 sites from the Crohn's & Colitis Foundation Clinical Research Alliance.

25 ARC IBD) from the IBD Plexus registry of the Crohn's & Colitis Foundation in the United States.

26 with a pathologic diagnosis of dysplasia in Crohn's colitis from 1987 to 2009 were identified.

27 the mucosal and submucosal layers, although Crohn's colitis may be transmural.

28 t medical problems, consisting of ulcerative/Crohn's colitis (n=6), adrenal insufficiency (n=5), hema

29 use of the multifocal nature of dysplasia in Crohn's colitis, TPC is recommended in good-risk patient

30 We report on 259 patients with chronic Crohn's colitis who underwent screening and subsequent s

31 t a rare case of EC in the setting of severe Crohn's colitis with no clinical evidence of UTI.

32 Biopsies confirmed Crohn's colitis with no evidence of granulomata or dyspl